Inventor

PRESTA LEONARD

US52 patents

⚠️ This page may combine multiple inventors who share the name “PRESTA LEONARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PRESTA LEONARD

GENENTECH INC

Polypeptide variants with altered effector function

Polypeptide variants with altered effector function

Polypeptide variants with altered effector function

Polypeptide variants with altered effector function

Polypeptide variants with altered effector function

Polypeptide variants with altered effector function

Polypeptide variants with altered effector function

Polypeptide variants with altered effector function

Polypeptide variants with altered effector function

Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production

Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production

Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production

Chimeric receptors as inhibitors of vascular endothelial growth factor activity, and processes for their production

Methods for using chimeric vascular endothelial growth factor receptor proteins

Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates

Antibody fragment-peg conjugates

Methods of treating inflammatory disease with anti-IL-8 antibody fragment-polymer conjugates

COMPUGEN LTD

Anti-PVRIG antibodies and methods of use

Anti-PVRIG antibodies and methods of use

Anti-PVRIG antibodies and methods of use

Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof

Anti-PVRIG antibodies and methods of use

Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereof

Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof

Anti-PVRIG antibodies and methods of use

Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof

Anti-PVRIG antibodies and methods of use

Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof

SCHERING CORP

Neutralizing human anti-IGFR antibody

Neutralizing human anti-IGFR antibody

Neutralizing human anti-IGFR antibody

Neutralizing human anti-IGFR antibody

DAVIS-SMYTH TERRI LYNN

Methods of inhibiting vascular endothelial growth factor activity

Inhibitors of vascular endothelial growth factor activity

Compositions and methods for producing inhibitors of vascular endothelial growth factor activity

Methods for using inhibitors of vascular endothelial growth factor activity

BIOGRAPH 55 INC

Composite binding molecules targeting immunosuppressive B cells

CD19/CD38 multispecific antibodies

Anti-CD19/anti-CD38 common light chain bispecific antibodies

Anti-CD19/anti-CD38 common light chain bispecific antibodies

SCRIPPS RESEARCH INST

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

Optimized PNE-based chimeric receptor T cell switches and uses thereof

Humanized anti-CD3 antibodies, conjugates and uses thereof

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

PRESTA LEONARD

Polypeptide variants with altered effector function

Polypeptide variants with altered effector function

GENENTECH INC A MEMBER OF THE ROCHE GROUP

Nucleic acids encoding humanized anti-CD40 antibodies

INTERVET INC

Caninized murine antibodies to human PD-1

WANG YAN

Neutralizing human anti-IGFR antibody

SURROZEN OPERATING INC

Liver-specific Wnt signal enhancing molecules and uses thereof